Advances in the Treatment of Demodex Blepharitis : Episode 2

Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%

May 8, 2024

Opinion

Video

A key opinion leader examines the historical context of Demodex blepharitis treatment, discussing the efficacy and limitations of previous therapies, and emphasizes a recently FDA-approved therapy that directly targets Demodex mites, leading to improved efficacy compared to treatments that only address symptoms.

EP: 1.Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis

Now Viewing

EP: 2.Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%

EP: 3.In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs

EP: 4.Enhancing Patient Understanding and Treatment Adherence

EP: 5.K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!